Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

213 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Open prostatectomy for benign prostatic enlargement in southern Europe in the late 1990s: a contemporary series of 1800 interventions.
Serretta V, Morgia G, Fondacaro L, Curto G, Lo bianco A, Pirritano D, Melloni D, Orestano F, Motta M, Pavone-Macaluso M; Members of the Sicilian-Calabrian Society of Urology. Serretta V, et al. Urology. 2002 Oct;60(4):623-7. doi: 10.1016/s0090-4295(02)01860-5. Urology. 2002. PMID: 12385922
Management of symptomatic benign prostatic hyperplasia in southern Italy: a retrospective analysis of the Sicilian-Calabrian Society of Urology (SSCU) of 32,000 patients.
Serretta V, Morgia G, Fondacaro L, Curto G, Pirritano D, Lo Bianco A, Melloni D, Orestano F, Motta M, Pavone-Macaluso M; Members of the Sicilian-Calabrian Society of Urology. Serretta V, et al. Urol Int. 2003;71(1):16-21. doi: 10.1159/000071087. Urol Int. 2003. PMID: 12845254 Clinical Trial.
Use of alpha1-blockers in female functional bladder neck obstruction.
Pischedda A, Pirozzi Farina F, Madonia M, Cimino S, Morgia G. Pischedda A, et al. Urol Int. 2005;74(3):256-61. doi: 10.1159/000083559. Urol Int. 2005. PMID: 15812214
Preliminary report of a multicentric study on environmental risk factors in Ta-T1 transitional cell carcinoma of the bladder. A study from Gruppo Studi Tumori Urologici Foundation.
Serretta V, Morgia G, Altieri V, Pavone-Macaluso M, Scuto F, Allegro R, Di Lallo A, Cindolo L, Melloni D; Gruppo Studi Tumori Urologici Foundation. Serretta V, et al. Urol Int. 2006;77(2):152-8. doi: 10.1159/000093911. Urol Int. 2006. PMID: 16888422 Clinical Trial.
Transurethral resection of prostate: technical progress by bipolar Gyrus plasma-kinetic tissue management system.
Falsaperla M, Cindolo L, Saita A, Polara A, Bonaccorsi A, Scavuzzo A, Motta M, Morgia G. Falsaperla M, et al. Minerva Urol Nefrol. 2007 Jun;59(2):125-9. Minerva Urol Nefrol. 2007. PMID: 17571047 Clinical Trial.
RESULTS: The mean operative time was 89 min (range 48-121 min); the mean prostatic resected weight (measured by an electronic scales) was 49.6 g (3267 g). The mean decrease of haemoglobin level was 1.1 g/dL (range 0.5-1.9), with a mean catheterization time of …
RESULTS: The mean operative time was 89 min (range 48-121 min); the mean prostatic resected weight (measured by an electronic scales) was 49 …
Transurethral ethanol ablation of the prostate (TEAP): an effective minimally invasive treatment alternative to traditional surgery for symptomatic benign prostatic hyperplasia (BPH) in high-risk comorbidity patients.
Magno C, Mucciardi G, Galì A, Anastasi G, Inferrera A, Morgia G. Magno C, et al. Int Urol Nephrol. 2008;40(4):941-6. doi: 10.1007/s11255-008-9394-z. Epub 2008 May 14. Int Urol Nephrol. 2008. PMID: 18478352
Cigarette smoking and drinking water source: correlation with clinical features and pathology of superficial bladder carcinoma.
Serretta V, Altieri V, Morgia G, Allegro R, Ruggirello A, Di Lallo A, Carrieri G, Melloni D; Members of the foundation Gruppo Studi Tumori Urologici (GSTU). Serretta V, et al. Urol Int. 2009;82(3):318-23. doi: 10.1159/000209365. Epub 2009 May 11. Urol Int. 2009. PMID: 19440021 Clinical Trial.
METHODS: Tumor number, dimension, G-grade, T-stage, recurrences, cigarette smoking and water supply were recorded in patients harboring Ta-T1 G1-3 transitional cell carcinoma of the bladder. ...
METHODS: Tumor number, dimension, G-grade, T-stage, recurrences, cigarette smoking and water supply were recorded in patients harbori …
Vacuum-assisted closure for the treatment of Fournier's gangrene.
Cuccia G, Mucciardi G, Morgia G, Stagno d'Alcontres F, Galì A, Cotrufo S, Romeo M, Magno C. Cuccia G, et al. Urol Int. 2009;82(4):426-31. doi: 10.1159/000218532. Epub 2009 Jun 8. Urol Int. 2009. PMID: 19506410
Oral chemotherapy in hormone-refractory prostate carcinoma patients unwilling to be admitted to hospital.
Serretta V, Altieri V, Morgia G, Siragusa A, De Grande G, Napoli M, Falsaperla M, Melloni D, Allegro R. Serretta V, et al. Urol Int. 2009;83(4):452-7. doi: 10.1159/000251187. Epub 2009 Dec 8. Urol Int. 2009. PMID: 19996654 Clinical Trial.
213 results
Jump to page
Feedback